Login to Your Account



Other News To Note


Monday, June 3, 2013

• Xbiotech, of Austin, Texas, developed an antibody that neutralizes interleukin-6 (IL-6) using its True Human technology, cloned directly from a human immune response. The company is working on a manufacturing process for the antibody, and expects to begin clinical studies in early 2014.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription